Terray Therapeutics Funding: $60M Raised, Series A (2022)
Terray Therapeutics is a Biotech company based in Pasadena, California. It has raised $60M in total funding. Latest round: Series A. Backed by Madrona.
Terray Therapeutics funding overview
Terray Therapeutics is a Biotech company based in Pasadena, California. Terray Therapeutics has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in February 2022. The round record for Terray Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Madrona.
Terray Therapeutics at a glance
Total raised
$60M
Latest round
Series A
Latest round date
February 2022
Industry
Biotech
Headquarters
Pasadena, California
Notable investors
Madrona
Frequently asked about Terray Therapeutics funding
How much has Terray Therapeutics raised?
Terray Therapeutics has raised $60M in total disclosed funding across the rounds on record.
Who has invested in Terray Therapeutics?
Madrona are named among the investors backing Terray Therapeutics.
What was the latest Terray Therapeutics funding round?
The most recent disclosed round is a Series A, announced in February 2022.
Where is Terray Therapeutics based?
Terray Therapeutics is based in Pasadena, California.
What sector does Terray Therapeutics operate in?
Terray Therapeutics is tracked under Biotech from Pasadena, California, with $60M in disclosed funding.
When did Terray Therapeutics last raise?
The last disclosed Terray Therapeutics round closed in February 2022 at Series A.
Every Terray Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Pasadena at a similar stage.
